Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals (ICPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,551,286
  • Shares Outstanding, K 32,943
  • Annual Sales, $ 252,000 K
  • Annual Income, $ -344,680 K
  • 60-Month Beta 1.78
  • Price/Sales 6.08
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -2.91
  • Number of Estimates 11
  • High Estimate -2.20
  • Low Estimate -3.17
  • Prior Year -2.28
  • Growth Rate Est. (year over year) -27.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.50 +5.82%
on 06/29/20
83.57 -43.65%
on 06/23/20
-28.29 (-37.53%)
since 06/02/20
3-Month
44.50 +5.82%
on 06/29/20
95.98 -50.94%
on 05/12/20
-13.09 (-21.75%)
since 04/02/20
52-Week
44.50 +5.82%
on 06/29/20
125.00 -62.33%
on 12/31/19
-31.57 (-40.13%)
since 07/02/19

Most Recent Stories

More News
Biotech Stock Roundup: GILD Prices Remdesivir, VXRT Rises, ICPT Plunges & More

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline developments.

ALXN : 112.30 (-0.08%)
GILD : 76.35 (+0.38%)
VRTX : 291.10 (+1.68%)
ZGNX : 29.19 (+0.41%)
ICPT : 47.09 (+1.23%)
VXRT : 7.37 (-7.88%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or "the Company") (NASDAQ:...

ICPT : 47.09 (+1.23%)
Intercept Slumps as the FDA Issues CRL to NASH Candidate

Intercept (ICPT) down on receipt of CRL for its NDA seeking approval of OCA for the treatment of fibrosis due to nonalcoholic steatohepatitis (NASH).

VKTX : 6.68 (-5.78%)
GLMD : 4.83 (-0.41%)
ICPT : 47.09 (+1.23%)
GNFT : 5.44 (-1.45%)
Company News for Jun 30, 2020

Companies in the news are: KNSA, TLSA, COTY, ICPT

COTY : 4.45 (+3.01%)
ICPT : 47.09 (+1.23%)
KNSA : 23.73 (-7.05%)
TLSA : 6.51 (-2.84%)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Intercept Pharmaceuticals, Inc. (ICPT) on Behalf of Investors

Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Intercept Pharmaceuticals, Inc. ("Intercept" or...

ICPT : 47.09 (+1.23%)
Coty, Boeing rise; Intercept Therapeutics, Heron fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:

ICPT : 47.09 (+1.23%)
HRTX : 15.53 (-3.18%)
GILD : 76.35 (+0.38%)
BA : 180.81 (+0.27%)
COTY : 4.45 (+3.01%)
BNTX : 63.27 (-1.36%)
FLR : 11.70 (+2.01%)
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Intercept Pharmaceuticals, Inc. Investors (ICPT)

The Law Offices of Frank R. Cruz announces an investigation on behalf of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT) investors concerning the Company and its officers'...

ICPT : 47.09 (+1.23%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Intercept Pharmaceuticals, Inc. (ICPT) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT) investors concerning the Company and its officers' possible...

ICPT : 47.09 (+1.23%)
After Yesterday's Decline of 38.16%, Intercept Pharma Offers Investors Better Value

Intercept Pharma (NASDAQ:ICPT) traded in a range yesterday that spanned from a low of $44.50 to a high of $50.00. Yesterday, the shares fell 38.2%, which took the trading range below the 3-day low of...

ICPT : 47.09 (+1.23%)
Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

ICPT : 47.09 (+1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ICPT with:

Business Summary

Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company's lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR)....

See More

Key Turning Points

2nd Resistance Point 48.63
1st Resistance Point 47.86
Last Price 47.09
1st Support Level 45.70
2nd Support Level 44.30

See More

52-Week High 125.00
Fibonacci 61.8% 94.25
Fibonacci 50% 84.75
Fibonacci 38.2% 75.25
Last Price 47.09
52-Week Low 44.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar